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Alzhrani, Jasser Ali. M.S. Department of Pharmacology and Toxicology, Wright 
State University, 2015. Na+/K+ Pump and Cl--coupled Na+ and K+ cotransporters in Mouse 
Embryonic Fibroblasts lacking the Tuberous Sclerosis Complex 1 (TSC1) and Tuberous 
Sclerosis Complex 2 (TSC2) genes.  
The tuberous sclerosis complex 1 and 2 (TSC1 and TSC2) genes and their 
products hamartin and tuberin, respectively, are involved in several regulatory cellular 
mechanisms, including the mTOR pathway that is important for proliferation, cell 
migration, and protein synthesis. In addition, it has been suggested that this pathway plays 
a role in regulating Na+-K+-2Cl- and K+-Cl- cotransporters (NKCC and KCC, 
respectively) [41, 42, 43]. Therefore, the TSC1 and TSC2 genes are expected to play a 
significant role in regulating cell volume, and K+ and Cl- homeostasis. This study tests the 
hypothesis that the TSC1 and TSC2 genes, which control cell processes through the 
mTOR pathway, are important for the function of the Na+/K+ pump (NKP), Na+,K+,2Cl- 
and  K+,2Cl- cotransporters (KCC and KCC, respectively) and for the maintenance of 
intracellular K+ (Ki )  content  in mouse embryonic fibroblasts (MEF) cells. The cellular 
models are wild type (WT) and knockouts (KO) of the TSC1 or TSC2 genes, TSC1-KO 
and TSC2-KO, respectively. K+ homeostasis was assessed through the activities of NKP, 
NKCC and KCC determined by rubidium (Rb+, a K+ congener) influx and Ki content in 
the presence and absence of the NKP-inhibitor ouabain, the NKCC-inhibitor bumetanide 
and by Cl--dependent Rb+ influx via KCC. Optimal ouabain and bumetanide 
concentrations were obtained from the dose-response curves of Rb+ influx and Ki content 
inhibition toward these compounds. In support of the hypothesis, the main findings 
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indicate that absence of the TSC1, and especially, the TSC2 gene, which are associated 
with depression of the mTOR pathway [4, 5, 8], leads to accelerated cell proliferation and 
migration, and abnormal activities of all the transporters tested revealing the importance 
of the TSC1 and TSC2 gene products, hamartin and tuberin, respectively, in cellular K+ 
homeostasis in MEF cells. Moreover, abnormalities in ion transport of TSC2-KO cells is 
commensurate with the pathological manifestation and incidence of tuberous sclerosis 
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1.  Introduction  
Most cellular functions crucially depend on cell volume. In addition, the structure 
and function of molecules, and especially of macromolecules such as enzymes, are altered 
by hydration [1]. The cellular membrane is highly permeable to water and is responsive to 
changes in the intracellular or extracellular osmolality. The cell membrane’s permeability 
to Na+, K+ and Cl- ions is orders of magnitude lower than that to water Therefore, in order 
to maintain a stable cell volume, all cells express various transport proteins for Na+, K+ and 
Cl- across the cell membrane [1, 2].  
A brief overview of cell volume regulatory mechanisms will be given here. When 
cells are exposed to several osmolalities such as hypotonic, isotonic or hypertonic, they 
may undergo volume changes and become swollen, normal or shrunken, respectively. 
Swollen cells may undergo regulatory volume decrease (RVD) by releasing ions, 
particularly activation of volume-sensitive Cl- and K+ channels and K+- Cl- cotransport 
(KCC). Shrunken cell may undergo regulatory volume increase (RVI) by taking up ions, 
particularly through  the Na+/H+ exchanger, Na+- K+- 2Cl- co-transporter (NKCC), and non-
selective cation channels [1, 2] (Fig. 1).  
We explore in this study the characteristics of the Na+/K+ Pump and Cl--coupled 
Na+ and K+ co-transporters (NKCC and KCC) in mouse embryonic fibroblasts (MEFs) 
lacking the tuberous sclerosis complex-1 (TSC1) and -2 (TSC2) genes. The cell models 
used are wild type (WT), TSC1-KO, and TSC2-KO. Before providing a more detailed 
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description of the study, a brief introduction about TSC 1 and 2, the mammalian target of 
rapamycin (mTOR) complex 1 and 2, NKP, NKCC, and KCC will be presented.  
 
Figure 1 - Effectors involved in regulatory volume decrease (RVD) and regulatory 
volume increase (RVI) [32].  The main effectors in RVI in most cell types are Na+/H+ 
exchangers (NHEs), the Na+-K+-2Cl−Cotransporters (NKCCs), anion exchange (AE), 
hypertonicity-induced cation channels (HICCs), and Na-dependent transporters for 
organic osmolytes. However, the main effectors in RVD are swelling-activated 
Cl− channels (Icl,vol), swelling-activated K+ channels (Ik,vol), anion exchange (AE), the K+-
Cl− cotransporters (KCCs), and organic osmolyte efflux pathways. 
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1.1. Tuberous sclerosis complex 1 (TSC1) and 2 (TSC2)  
The tuberous sclerosis complex (TSC) is a multisystem tumor suppressor [3, 4] and 
its genetic autosomal dominant aberration causes non-malignant tumors to form in multiple 
organs, such as brain, kidney, heart, skin and lungs. TSC abnormalities usually cause 
neurologic disorders such as mental problems (retardation), epilepsy, delays in cognitive 
development, and autism. In addition to neurological disorders, other manifestation of 
tuberous sclerosis include facial angiofibromas, pulmonary lymphangiomyomatosis, and 
renal angiomyolipomas [3].  
The severity and incidence of TSC can vary between patients and is inherited from 
a spontaneous genetic mutation or from one parent suffering from the disease. Affected 
parents will have half of their children most likely inheriting TSC. Either the TSC1 or TSC2 
genes need to be affected for the manifestation of the disease [3, 4].  
The heterodimeric complex that TSC1 and TSC2 proteins form is considered an 
essential integrator of numerous pathways that are involved in controlling mTOR, and 
particularly mTORC1 activity [4, 5]. The TSC1 gene is located on chromosome 9 and its 
open reading frame (ORF) encodes the 130 kDa protein TSC1 (hamartin). This protein has 
1164 amino acids. On the other hand, the TSC2 gene encodes the 200 kDa protein TSC2 
(tuberin), consisting of 1807 amino acids, and the gene is positioned on chromosome 16 
[5]. Both activating and inhibitory phosphorylation events at particular amino acid residues 




Figure 2 - Structure of TSC1 and TSC2. TSC1 (hamartin) interacts with the N-terminal 
418 amino acids (aa) of the 1807 aa long tuberin through a 138 aa specific region within 
the N-terminal half of its 1164 amino acids. [3]. 
TSC2 contains a C-terminal GTPase activating protein (GAP) domain. This domain 
stimulates GTPase activity toward GDP-Rheb, which means that when the GTPase is 
activated by TSC2, it converts GTP-Rheb to GDP-Rheb. This conversion inhibits 
mTORC1; whereas when Rheb is in its GTP bound form it is an activator of mTORC1 [9, 
10] (Fig. 3). The complex TSC1-TSC2 is inhibited by Protein kinase B (PKB/AKT) which 
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is a serine/threonine protein kinase that plays an important role in such as apoptosis, cell 
proliferation, cell migration, and transcription. This inhibition occurs through 
phosphorylation of TSC2 by AKT on 2-5 sites, although the mechanism at the molecular 
level is still unknown because the activity of GAP is not significantly affected by the 
various phosphorylation events [7, 8]. TSC1 prevents TSC2 from degradation, so it acts as 
a stabilizer of TSC2 (tuberin) [9, 10]. The adenosine monophosphate-dependent protein 
kinase (AMPK) usually activates the complex by phosphorylating only 2 residues of TSC2 
[11] (Fig. 3).   
1.2. Mammalian Target of Rapamycin (mTOR)  
 There are several names for mammalian (mechanistic) target of rapamycin (mTOR) 
such as FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1). mTOR is a 
serine/threonine protein kinase that forms two complexes, each with specific functions. 
These complexes are mTORC1 and mTORC2 and are encoded by the mTOR gene [3, 5]. 
mTOR regulates the most important cellular functions that have direct role in cell survival 
such as cell growth, motility, proliferation, transcription, and protein synthesis [12]. 
Activation and function of mTORC1 and mTORC2 are affected in different ways by the 
localization of each protein because both localize to different subcellular compartments 
[13].  
M-TORC1 is considered to be a sensor for energy, nutrition, and 
reduction/oxidation. It regulates protein synthesis, and is composed of different proteins,  
mTOR, RAPTOR,  mLST8, G protein beta subunit-like (GβL), and most importantly, it is 
6 
 
highly sensitive to rapamycin [5] (Fig. 3). Growth factors, insulin, serum, and amino acids, 
stimulate the activity of mTORC1. In contrast, mTORC2 consists of mTOR, Rictor, 
mLST8, GβL and mSIN1 and it is considered as an essential controller of the cytoskeleton 
[14] (Fig. 3).  
M-TORC2 also phosphorylates Akt at the serine residue S473, therefore influencing 
survival and metabolism [15]. Akt phosphorylation leads to a second phosphorylation, 
specifically at a threonine residue T308 by phosphoinositide-dependent protein kinase 1 
(PDK1). These two phosphorylation events cause full activation of Akt [16, 17] (Fig. 3). 
The major difference between mTORC1 and mTORC2 is that mTORC1 is acutely and 
precisely inhibited by rapamycin, whereas rapamycin’s effects on mTORC2 are more 




Figure 3 - PI3K–Akt–mTOR signaling [6]. The phosphatidylinositol 3'-kinase–Akt– 
mammalian target of rapamycin (PI3K–Akt–mTOR) pathway is shown in Figure 3. 
Energy or amino acid depletion, hypoxia, calcium homeostasis, rapamycin, and 5amino-
4-imidazolecarboxamide ribose (AICAR) are the most important points in this pathway 
[6]. Abbreviations in this figure are phosphatidylinositol 3'-kinase–Akt– mammalian 
target of rapamycin (PI3K–Akt–mTOR); 5 amino-4-imidazolecarboxamide ribose 
(AICAR); eukaryotic initiation factor (eIF); Eukaryotic initiation factor 4E (eIF4E); 
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eIF4E binding protein (4E-BP); 4F cap-binding complex (eIF4); AMP-activated kinase 
(AMPK); mitogen-activated protein kinase-interacting kinase 1 (Mnk1); 
phosphoinositide-dependent protein kinase 1 (PDK1); phosphatidylinositol-4,5-
bisphosphate (PtdIns(4,5)P2); phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3); 
regulatory associated protein of TOR (raptor); rapamycin-insensitive companion of 
mTOR (rictor); ribosomal protein S6 (S6); p70S6 kinase (S6K); tuberous sclerosis 
complex (TSC). 
 The mechanism of mTOR inhibition by rapamycin is by association to intracellular 
FK506 binding protein (FKBP12) to form the FKBP12-rapamycin complex. This complex 
binds to an mTOR domain and this binding process causes inhibition of the mTOR activity. 
The most important information is that rapamycin inhibits mTORC1 in acute doses thus 
providing the ultimate favorable effects of the drug. However, rapamycin has a complex 
effect on mTORC2 because it inhibits it only in certain cell types and under extended 
exposure. Furthermore, the mTOR complex incorporates growth factors (IGF-1 and IGF-
2), insulin, and amino acids which are considered up-stream’s input pathways [18].  
The mTORC1 signaling, which is commonly present in normal cells, inhibits 
insulin signaling by a negative feedback effect to monitor and limit the signaling of Akt. 
The mTORC1-S6K1 signaling leads to attenuation of PI3K activation downstream of 
insulin and the insulin receptor substrate proteins, IRS1 and IRS2. However, in cells 
responding to chronic activation of mTORC1, such as those lacking a functional TSC1-
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TSC2 complex, this mechanism of negative feedback inhibits the signaling of Akt affecting 
its downstream pathways involved in cell survival and proliferation [4, 5]. 
1.3. Na+-K+ pump (NKP), Na+-K+-2Cl- cotransport (NKCC), and K+-Cl- 
cotransport (KCC)  
A) Na+/K+ Pump (NKP)  
The Na+/K+ Pump (sodium-potassium pump) promotes active transport of Na+ and 
K+ ions with expenditure of adenosine tri-phosphate (ATP) as cellular energy. NKP is 
localized in the cell membrane of most cell types and pumps three sodium ions outside of 
the cell and two potassium ions inside. This pump is responsible for creating ionic gradients 
whereby cells maintain a steady-state characterized by high concentrations of intracellular 
K+ and low concentrations of Na+, and it is not considered an anti-porter because both K+ 
and Na+ are moving against their concentration gradients. NKP, discovered in the 1950s by 
a Danish scientist, Jens Christian Skou, helps control the resting membrane potential, 
regulate cellular volume, and most importantly, functions as an integrator to regulate the 
mitogen-activated protein kinases (MAPK), intracellular calcium, and reactive oxygen 
species (ROS) [1, 19].  
In the operational cycle of NKP, three Na+ ions bind to the pump and one ATP 
molecule induces a conformational change which in turn moves the ions through the pump. 
One phosphate group from ATP remains bound to the channel, the Na+ ions are released on 
the other side of the membrane and the new conformation of NKP acquires high affinity 
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for K+ which binds to NKP for translocation to the intracellular compartment [1, 19]. This 
binding is also causing a conformational change in NKP making it to release the phosphate 
group into the cytoplasm. This process allows NKP to change to its original conformation 
and as a result, the K+ ions will be released into the cell. In its normal conformation, NKP 
has a high affinity for Na+ ions but it is only when these ions bind to the pump that another 
cycle is initiated. The movement of Na+ and K+ against their concentration gradients, i.e. 
from low to high concentrations is only possible by constant consumption of ATP by the 
pump [1, 2, 19].  
NKP is a heterotrimer containing three subunits: α, β, and γ [20]. The alpha subunit 
has a molecular mass of 112 kDa, is considered a multispanning membrane protein, and is 
responsible for the transport properties of the enzyme. The α-subunit contains the binding 
sites for ATP, cations, and ouabain [21].   
There are four α-subunits which are α1, α2, α3, and α4 in animal cells, the α2 subunit 
is the more abundantly expressed and is the most sensitive to ouabain. However, in humans, 
α1 is the most sensitive to this drug. The β-subunit is a polypeptide of 40-60 kDa molecular 
weight, and crosses the plasma membrane. This subunit is crucial for the activity of the 




B) Na+-K+-2Cl- Co-transport (NKCC)  
The membrane-bound NKCC protein plays a critical role in variety of epithelial 
process, namely absorption and secretion. Beside that NKCC promotes bidirectional 
transport of Na+, K+, and 2 Cl- ions. NKCCs are strongly involved in cell volume and cell 
cycle regulation. Two NKCC isoforms are currently known. While NKCC2 seems to be 
present restrictively in the kidney, NKCC1, the house-keeping form, is present in almost 
all cells [20, 22, 28, 29].   
There are two different genes (SLC12A2 and SLC12A1) encoding NKCC1 and 
NKCC2, respectively, see Table 1. NKCC transports Na+, K+ and Cl-, and can be blocked 
by bumetanide, a loop diuretic. NKCC is not driven by a membrane voltage because it is 
electroneutral requiring Na+, K+, and 2Cl- to be present simultaneously on the same side of 
the cell membrane to be transported in or out of the cells, depending on the ionic gradients 
[20, 22, 29]. One ion increases the affinity for the other ions to bind to NKCC when a Na+, 
K+, or Cl- ion is binding to the cotransport. More specifically Na+ binds first and then Cl-, 
followed by K+ and a second Cl- externally. According to the “gliding symmetry model”, 
internally, the Na+ is released first and then the first Cl-, followed by the K+ and finally by 
the second Cl- [48]. In other words, ions depend on each other to increase the binding site 
affinity for the remaining ions. NKCC is activated by phosphorylation and deactivated by 
de-phosphorylation. Phosphorylation of NKCC is mediated by protein kinase C (PKC), 
protein kinase A (PKA), with no lysine kinase (WNK), and Ste20-related proline-alanine-
rich kinase (SPAK) [34], whereas de-phosphorylation is mediated by protein phosphatases. 
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Moreover, the concentrations of ions such as Cl-, Na+, Ca2+, K+, and Mg2+ directly affect 
NKCC activity [20, 22, 28-30].  
Gene    Species  Gene Symbol  
NKCC1  Mouse Slc12a2  
NKCC2  Mouse  Slc12a1  
Table 1 - Genes encoding the Na+-K+-2Cl- cotransporters. 
C) K+-Cl- Co-transport (KCC)  
KCCs promote electroneutral K+ and Cl- cotransport and are involved in the Na+-
independent K+ transport into or out of the cell, depending on the ionic gradient. KCCs 
preserve intracellular Cl- and K+ homeostasis, and ultimately maintain cell volume [20, 22, 
30, 31].   
The Cl--dependent K+ transport system was first recognized in sheep and fish red 
blood cells (RBCs) as a swelling-activated K+ flux [26, 27, 49, 63, 64, 65]. KCCs have four 
protein isoforms KCC1 to KCC4 and are encoded by four genes SLC12A4 to 7 
respectively, possessing splice variants in each isoform. The KCC1 gene is located on 
chromosome 16.q22.1, and its ORF translates a 1085 amino acids protein that fulfills house-
keeping function by regulating volume homeostasis in most tissues [36, 37, 65]. KCC2, 
located on chromosome 20, occurs in two spliced variants KCC2a and KCC2b. KCC2b, 
which is only present in the brain, whereas the second and longer variant KCC2a occurs 
not only in the brain but also in other tissues such as the lens and myocardium [20, 22, 26, 
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27, 36, 37, 65] . The third isoform is KCC3 and it is located on chromosome 15.q13. It is 
usually found in skeletal muscle, brain, heart, pancreas and kidney. KCC3 has two major 
isoforms, KCC3a which has 1150 amino acids, and KCC3b that has 1099 amino acids, both 
mainly expressed in the kidney [20, 22, 36, 37].  
The last isoform, KCC4 which has 1083 amino acids, located on chromosome 5p15, 
and is expressed in different tissues such as thymus, spleen, spinal cord, brain, bone 
marrow, pancreas, liver, skeletal muscle, lung, and the heart. KCCs function can be 
appreciated when the extracellular medium becomes hyposmotic, inducing water to enter 
the cell and causing an increase in cell volume. This activates volume-sensitive K+ and Cl- 
channels and the KCCs, which extrude K+ and Cl- ions and water in order to bring the 
volume of the cell back to its original volume [20, 22, 23, 65]. Along with regulating cell 
volume, KCCs have been found to be involved in numerous pathologies, cell migration, 
and cell growth [38]. KCCs also play important roles in sickle cell disease, cardiovascular 
diseases, and tumor biology [33, 61, 62, 63, 64, 65].  
2.  Hypothesis and Specific Aims  
2.1.  Background for hypothesis  
The two functionally important genes TSC1 and TSC2 in MEFs are positioned on 
chromosomes 9q34 and 16p13.3, respectively, and encode the 130 kDa hamartin and 200 
kDa tuberin proteins, respectively [3, 4]. MEFs TSC1-KO and TSC2-KO cells have high 
mTORC1 activity [4, 5] that may lead to activation of NKCC [41, 42] and deactivation of 
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KCC [43, 44] as we expected. Therefore, NKCC’s and KCC’s activities should be increased 
and decreased with respect to WT cells. Our studies showed activation of NKCC through 
increased Rb+ (K+) influx and deactivation of KCC through decreased Rb+ (K+) influx. 
Based on these data, we propose the following hypothesis.  
2.2. Hypothesis  
  The TSC1 and TSC2 genes, which control cell processes through the mTOR 
pathway, are important for K+ homeostasis and transport through the Na+/K+ Pump (NKP), 
Na+-K+-Cl- (NKCC) and K+-Cl- (KCC) cotransports in mouse embryonic fibroblasts 
(MEFs).  
I) Specific Aim 1  
Determine the optimal conditions for K+ movements requiring metabolic energy 
(Na+/K+ pump) to assess the role of the TSC1 and TSC2 genes and the mTOR pathway on 
K+ homeostasis. This will be accomplished by determination of the optimal ouabain 
concentration for Rb+ influx and Ki content in WT, TSC1-KO, and TSC2-KO MEF cells. 
II) Specific Aim 2 
Determine the optimal conditions for K+ movements through pathways indirectly 
dependent on metabolic energy (Na+-K+-Cl- and K+-Cl- cotransport) to assess the role of 
the TSC1 and TSC2 genes and the mTOR pathway on K+ homeostasis. This will be 
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accomplished by determination of the optimal bumetanide concentration for Rb+ influx and 
Ki content in WT, TSC1-KO, and TSC2-KO MEF cells. 
III) Specific Aim 3 
Determine K+ movements under physiological conditions to assess the role of the 
TSC1 and TSC2 genes and the mTOR pathway on K+ homeostasis and to determine 
whether they behave as expected for adult Mouse cells. This will be accomplished by 
characterization of Rb+ (K+) influx and Ki content in the presence and absence of inhibitors 
of NKP, NKCC, and KCC at their optimal concentrations in WT, TSC1-KO and TSC2KO 
MEF cells.  
 3.  Materials and Methods 
 3.1.  Cell Models  
These cell models were provided by Dr. Kristopher T. Kahle, M.D. Ph.D. from 
Harvard Medical School. Wild type (WT) MEF cells were used as controls. These cells 
possess non tumorigenic characteristics [39], normal cell size and become confluent in 
about 4 days, according to our observations. TSC1-KO and TSC2-KO MEF cells are used 
as a model of increased mTORC1 activity and S6K expression, accelerated cell 
proliferation and growth, and are tumorigenic [3]. According to our observations, these 
cells become confluent in about 2 days and are of larger size than WT cells. 
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 3.2.  Chemicals   
Chemicals used in this study were: From Fisher Scientific: sodium chloride (NaCl), 
potassium chloride (KCl), magnesium chloride (MgCl2), sucrose, sodium hydroxide 
(NaOH), D-glucose, 70% perchloric acid (70% PCA), bicinchonic acid (BCA) protein 
assay reagents, and Tri-hydroxyamino methane (Tris) free base. Magnesium gluconate was 
from Sigma-Aldrich (St. Louis, MO). Chemicals from J.T.Baker Chemical Co (Center 
valley, PA) were: calcium chloride (CaCl2), anhydrous and (4-(2-hydroxyethyl)-
1piperazine ethane sulfonic acid (HEPES) free acid. High purity rubidium chloride (RbCl) 
99.9% and amidosulfonic acid (sulfamic acid, S) were purchased from Alfa Aesar (Ward 
Hill, MA); Cesium chloride (CsCl) from Life technologies (Carlsbad, CA) and calcium 
gluconate from Acros Organics (NJ).  
 3.3. Inhibitors  
Ouabain octahydrate was from Calbiochem (San Diego, CA) and bumetanide was 
from Sigma-Aldrich (St. Louis, MO). 
3.4.  Solutions for flux studies  
Washing solutions  
Balanced salt solution with sodium chloride (BSS-NaCl) (mM): 20 Hepes-Tris, 5 
KCl, 2 CaCl2, 1 MgCl2, 10 glucose and NaCl, pH 7.4, 37 °C, 300 mOsM.  
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Balanced salt solution with sodium gluconate (BSS-Na+ gluconate) (mM): 20 
Hepes-Tris, 5 K+ gluconate, 2 Ca-gluconate, 1 Mg-gluconate, 10 glucose and Na+-
gluconate, pH 7.4, 37 °C, 300 mOsM.  
Pre-incubation solutions  
Balanced salt solution with sodium chloride and bovine serum albumin  (BSS-NaCl-
BSA) (mM): 20 Hepes-Tris, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 0.1 % BSA and NaCl, 
pH 7.4, 37 °C, 300 mOsM.  
Balanced salt solution with sodium gluconate and bovine serum albumin (BSS-Na+ 
gluconate-BSA) (mM): 20 Hepes-Tris, 5 K+ gluconate, 2 Ca gluconate, 1 Mg gluconate, 10 
glucose, 0.1 % BSA and Na+ gluconate, pH 7.4, 37 °C, 300 mOsM.  
Flux solutions  
Balanced salt solution with rubidium chloride, sodium chloride, and bovine serum 
albumin (BSS-RbCl-NaCl-BSA) (mM): 20 Hepes-Tris, 10 RbCl, 2 CaCl2, 1 MgCl2, 10 
glucose, 0.1 % BSA and NaCl, pH 7.4, 37 °C, 300 mOsM.  
Balanced salt solution with rubidium sulfamate, sodium gluconate, and bovine 
serum albumin (BSS-RbS-Na+ gluconate-BSA) (mM): 20 Hepes-Tris, 10 Rb+ sulfamate, 2 





Final wash solution 
10 mM of 3-(N-Morpholino) propane sulfonic acid (MOPS)-Tris, MgCl2, pH 7.4, 
37 °C, 300 mOsM.  
Rb+ Extraction   
5 % perchloric acid, 4 mM CsCl  
Protein dissolution  
1M NaOH  
3.5. Cell cultures  
Mouse embryonic fibroblasts (MEFs) WT, TSC1-KO, and TSC2-KO were cultured 
in Dulbecco's Modified Eagle (DMEM) high glucose medium + L-glutamine + 110 mg/L 
sodium pyruvate (Life Technologies, Catalog No.11995-073) supplemented with 10 % 
premium fetal bovine serum (FBS) (Atlanta Biologicals, Catalog No.S11150), 100 units/ml 
penicillin (Hyclone, Catalog No. SV30010), 100 µg/mL streptomycin (Hyclone, Catalog 
No. SV30010) in a humidified incubator with 5 % CO2 at 37 °C. Washing buffer 1X 
phosphate buffer solution (PBS) (8 g  NaCl + 0.2 g KCl + 1.44 g Na2HPO4 + 0.24 g 
KH2PO4 dissolved in 1000 ml deionized H2O, pH 7.4) and 0.5 % TrypsinEDTA as to 
remove adherent cells from a culture surface (Life Technologies, Catalog No.15400-054). 
Cell freezing was done in dimethyl sulfoxide (DMSO, Life Technologies, Catalog 
No.D8418-50) at a concentration of 10 % of the freezing medium.  
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 3.6. BCA Protein Assay  
Proteins were determined by the bicinchoninic acid (BCA) assay, BCA™, 
consisting of two reagents, Protein Assay Reagent A (50 parts) and B (1 part), and is a 
colorimetric assay that detects proteins by changing color from green to purple [24]. 
Proteins in the NaOH extract were determined by adding 12.5 µl aliquot to each well of a 
96-well microplate (Life Technologies, catalog # 23252) by using an electronic pipette. The 
96-well plate was incubated for 30 min at 37 °C and cooled down for 10 min at RT 
following quantification by using a Labsystems MultiskanMCC/340 plate reader, according 
to the manufacturer’s instructions.  
3.7.  Ion Flux Studies  
Ion fluxes were determined according to previously published protocols [25, 26, 27] 
with some modifications. Cells were grown to 85 % confluence in 12-well plates. WT, 
TSC1-KO, and TSC2-KO MEFs were removed from the incubator, the culture medium 
was aspirated, cells were washed three times with 1mL of 300 mOsM BSS-NaCl or BSS-
Na+ gluconate and then equilibrated in BSS-BSA-NaCl or BSS-BSA-Na+ gluconate, pH 
7.4, 37 °C for 10 min, thereafter supernatants were removed and then exposed to pre-
warmed flux media BSS-BSA-RbCl or BSS-BSA-RbS for pre-determined time points (2.5 
min to 10 min). Thereafter, cells were washed with washing solution at room temperature 
(RT) to block Rb+ influx or Ki loss. Cellular Rb+ and K+ were extracted after cell lysis by 
exposing them for 15 min to ice cold 5 % PCA + 4 mM CsCl, the remaining solution was 
aspirated and protein was extracted by dissolving the attached cells in 1 M NaOH. Rb+ and 
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K+ were measured by atomic emission and absorption spectrophotometry, respectively 
using a Perkin Elmer 5000 Atomic Absorption Spectrophotometer. Protein was determined 
by the BCA assay [24] as described above. Rb+ uptake or Ki content were calculated in 
nmoles/mg protein as a function of time. Where indicated, ouabain (2 mM) and bumetanide 
(20 µM) were added to the flux media to block NKP and NKCC, respectively. The ouabain- 
and the bumetanide-sensitive Rb+ influx in Cl- medium are defined as NKP and NKCC, 
respectively, whereas KCC is defined as the (ouabain + bumetanide)-insensitive Cl--
dependent Rb+ influx and was obtained by subtracting the Rb+ influx in Cl- medium minus 
that in non-Cl- medium (sulfamate or gluconate replacement) containing the two inhibitors 
.  
3.8.   Statistical Analysis  
STATISTIX 7 software, (Graphpad Software, La Jolla CA) and (Analytical 
software, Tallahassee FL) from Graphpad Prism 5. These programs were used to determine 
statistical significance by one-way ANOVA, Wilcoxon signed rank test, Kruskal-Wallis 
ANOVA, and paired or unpaired t-test. Graphs, diagrams, and charts were plotted using 
Origin 7 software and Origin Pro 8.5 Student Version (Origin Labs, Northampton MA).  
Data were considered statistically significant for p-values < 0.05. 
4.  Results 
The purpose of this study was to understand the role of the TSC1 and TSC2 genes 
and their control of the mTOR signaling pathway on K+ homeostasis. To this end, we used 
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cellular models lacking each of the genes and their respective controls, i.e. WT, TSC1-KO 
and TSC2-KO MEF cells, and determined the function of key transporters known to be 
involved in the maintenance of K+ and cellular volume homeostasis, and in cell migration 
and proliferation. The transporters are the Na+/K+ pump and the Cl--coupled Na+ and K+ 
co-transporters, i.e. NKP, NKCC and KCC. In addition, the TSC1 and TSC2 genes and 
their products hamartin and tuberin, respectively, control cell processes through the mTOR 
pathway which is important for cell migration, proliferation, and protein synthesis. 
Therefore, we proposed that the TSC1 and TSC2 genes and the mTOR pathway play a 
significant role in regulating NKP, NKCC and KCC. Thus, as we hypothesized, the TSC1 
and TSC2 genes are expected to play a significant role in regulating cell K+ and Cl- 
homeostasis and cellular volume. We assessed K+ homeostasis through the activities of 
NKP, NKCC and KCC determined by rubidium (Rb+, a K+ congener) influx and Ki content 
in the presence and absence of the NKP inhibitor ouabain, the NKCC inhibitor bumetanide 
and by the Cl--dependent Rb+ influx via KCC. 
The results are presented with a logic dictated by the scant information available for 
these cell models regarding the conditions under which to determine Rb+ influx and Ki 
content; this information was mostly borrowed from knowledge of other cultured cells. 
Because of the novelty of our studies, we determined the parameters in question in the 
absence and presence of inhibitors under different conditions to learn whether MEF cells 
behave like adult murine cells (Specific Aims 1-3). It was also necessary to determine the 
optimal concentrations of the inhibitors ouabain and bumetanide to measure Rb+ influx and 
Ki content in MEF cells (Specific Aims 1 and 2). Lastly, the characterization of Rb+ (K+) 
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influx and Ki content was done under physiological conditions applying the knowledge 
gained in the preceding studies to determine whether the TSC1 and TSC2 genes are 
determinants of K+ homeostasis through the mTOR pathway in MEF cells (Specific Aim 
3).  
4.1. Rb+ influx and Ki content in WT, TSC1-KO and TSC2-KO in MEF cells in the 
absence of inhibitors. 
Previous studies in MEF cells provide information on ion transport and cell 
migration. For instance, iron homeostasis is regulated by mTOR through modulation of the 
transferrin receptor 1 (TfR1) stability and by altering cellular iron transport [50].  Inversin 
controls cell migration processes through transcriptional regulation of genes that control 
cytoskeletal organization and ion transport [51]. Presenilin expression affects copper and 
zinc transport in MEF cells [52]. However, no detail studies on K+ homeostasis in MEF 
WT, TSC1-KO, and TSC2-KO have been done. The present study was designed to fill this 
gap in knowledge. Thus, an initial step was to assess the relative magnitudes of Rb+ influx 
and intracellular K+ in WT, TSC1-KO, and TSC2-KO MEF cells in the absence of inhibitors 







Figure 4 – Rb+ influx and Ki content in WT, TSC1-KO and TSC2-KO in MEF cells 
in the absence of inhibitors. Rb+ influx was determined as described in Materials and 
Methods. Flux time, 5 min. Number of individual determinations (n) for WT, TSC1-KO , 
and TSC2-KO cells were n = 14, 21 and 16, respectively. Values are means ± S.E. Details 
are discussed in the text. 
Both the Rb+ influx and Ki content for the three cell types were statistically different 
and followed the sequence WT >  TSC1-KO > TSC2-KO MEF cells suggesting that cells 
lacking or with abnormalities in the TSC2 gene cause more detrimental effects on K+ 
homeostasis than the TSC1 gene. This finding is in line with the fact that abnormalities in 
the TSC2 gene are more severe and common in the TSC patient population [3, 53, 54, 55, 
56]. 
4.2. Studies on the Na+/K+ pump activity in WT, TSC1-KO and TSC2-KO in MEF 
cells. 
Due to lack of information in the literature concerning the optimal conditions to 
measure the activity of NKP in WT, TSC1-KO, and TSC2-KO MEFs, the first step was to 
do ouabain dose-response (ODR) curves for Rb+ influx [Figures 5 and 6] and Ki content 
[Figures 7 and 8] to determine the maximal ouabain inhibitory concentration (OSmax). 
Figure 5 shows inhibition of Rb+ influx at the ouabain concentrations tested (0-2.5 mM) for 
the 3 cell types with the relative values of Rb+ influx following the sequence WT > TSC1-
KO > TSC2-KO at 0 mM ouabain whereas that of the mean values obtained by averaging 
the Rb+ influx from the ODR curves for each cell type was WT ~ TSC1-KO > TSC2-KO.  
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The effect of ouabain on Ki content and its averages from ODR curves done in WT, 
TSC1-KO and TSC2-KO MEF cells are represented in Figures 7 and 8, respectively.  As 
expected for cellular K+, increasing the ouabain concentration did not affect Ki content in 
WT and TSC1-KO cells (Figure 7) because K+ enters the cell through NKP but exits 
through other pathways (K+ channels, NKCC, KCC and others), which are not sensitive to 
ouabain. In contrast, in TSC2-KO cells, Ki content decreased with increasing ouabain 
concentrations, which is unexpected in light of the findings in WT and TSC1-KO cells. In 
addition, TSC2-KO cells lost about 80 % of the intracellular K+ with respect to WT cells 
(Figure 8).  These results albeit unexpected once more confirm that lack of or abnormalities 
in the TSC2 gene appear to have detrimental effects on K+ homeostasis. 
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a) Determination of the optimal ouabain concentration for Rb+ influx and Ki 
content in WT, TSC1-KO, and TSC2-KO. 
 
Figure 5 - Ouabain-dose response (ODR) of Rb+ influx in WT, TSC1-KO, and 
TSC2-KO MEF cells. Rb+ influx was determined as described in Materials and Methods. 
Flux time, 5 min. Number of individual determinations (n) for WT, TSC1-KO , and 
TSC2-KO cells were n = 6, 12 and 6, respectively. Values are means ± S.E. Details are 




Figure 6 – Rb+ influx averages from ouabain dose-response of Rb+ influx in WT, 
TSC1-KO, and TSC2-KO MEF cells. Rb+ influx was determined as described in 
Materials and Methods. Flux time, 5 min, Rb+ influx averages in this figure were 
calculated as the sum of all the values of Rb+ influx at each ouabain concentration (0, 0.1, 
0.5, 1, 1.5, 2, 2.5 mM) divided by the number of ouabain concentrations used (7 for each 
cell line). Number of individual determinations (n) for WT, TSC1-KO, and TSC2-KO 





Figure 7 - Effect of increasing concentration of ouabain on Ki content in WT, TSC1-
KO, and TSC2-KO MEF cells. Ki content was determined as described in Materials and 
Methods after 5 min exposure to the indicated ouabain concentrations. Number of 
individual determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and 




Figure 8 – Averages of Ki content from ouabain dose-response curves in WT, TSC1-
KO, and TSC2-KO MEF cells. Ki content was determined as described in Materials and 
Methods after 5 min exposure to the indicated ouabain concentrations. Number of 
individual determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and 
6, respectively. Values are means ± S.E. Details are discussed in the text. 
As shown in figures 4-8, there were statistically significant differences in the 
response of TSC1-KO and TSC2-KO cells to ouabain. However, it was not clear whether 
the differences were due to the maximal ouabain inhibition, as it appears to be from the 
figures, and/or to differences in the sensitivity of the mutant cells to ouabain (the half 
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maximal ouabain inhibitory concentration (OIC50), Therefore, it was necessary to further 
characterize the effect of the TSC1 and TSC2 genes on K+ homeostasis and the response of 
the mutants to ouabain. To this end the maximal ouabain-sensitive (OSmax) and OIC50 were 
determined for Rb+ influx and Ki content in the three cell types.  
Figure 9 represents the calculated ouabain-sensitive (OS) Rb+ influx (NKP activity) 
from ODR curves as a function of the ouabain concentration for WT, TSC1-KO and TSC2-
KO MEF cells. The figure shows that inhibition of NKP activity in WT and TSC1-KO cells 
reach saturation at 2 mM ouabain, when the OSmax of WT cells is 121 nmoles/mg protein x 
5 min whereas that of TSC1-KO is about 50 % less than that. In contrast, inhibition of NKP 
by ouabain in TSC2-KO cells does not appear to saturate even at 2.5 mM ouabain and its 
value at that concentration is also 50 % of the WT. Because higher doses of ouabain caused 
cell detachment and were toxic to the cells, 2.5 mM was the highest dose used in this study 
(Figure 9 and Table 2). A plausible explanation for these findings will be given in the 
Discussion. The main message from these data is again that lack or abnormalities in the 
TSC1 and TSC2 genes lead to abnormal activity of one of the major pathways involved in 




Figure 9 - Determination of the maximal ouabain inhibitory concentration (OSmax). 
Rb+ influx was determined as described in Materials and Methods and the ouabain-
sensitive (OS) flux was calculated from ODR curves (see Figure 5) for each ouabain 
concentration. The OSmax was determined as the lowest dose saturation was reached. Flux 
time, 5 min. Number of individual determinations (n) for WT, TSC1-KO, and TSC2-KO 
cells were n = 6, 12 and 6, respectively. Values are means ± S.E. Details are discussed in 
the text. 
Studies in rat cells have shown that the α2 isoform of the Na+/K+ ATPase has higher 
affinity than α1 isoform for ouabain, in which the IC50 for α2 isoform is 0.01 – 0.5 mM and 
for α1 isoform is more than 10 mM [40]. The results shown in this study appear to be no 
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exception at least for the affinity for α2 isoform. To further assess the sensitivity of NKP 
to ouabain in the cell models in question, the half maximal ouabain inhibitory concentration 
(OIC50) was determined by assigning a value of 100 % to the OSmax for each WT, TSC1-
KO and TSC2-KO MEF cell type and calculating the percentages for each ouabain 
concentration shown in Figures 5-9.  
Figure 10 and the OIC50 values were obtained. As we can see in figure10 and Table 
2, the OIC50s in WT, TSC1-KO, and TSC2-KO are approximately 0.5, 0.6, and 0.6 mM, 
respectively, which are not statistically significantly different given the large dispersion in 




 Figure 10 - Determination of the half maximal ouabain inhibitory concentration 
(OIC50). Rb+ influx was determined as described in Materials and Methods and the 
ouabain-sensitive (OS) flux was calculated from ODR curves (see Figure 5) for each 
ouabain concentration. Ouabain-sensitive Rb+ influxes were calculated as percent of the 
OSmax, which was assigned arbitrarily a 100 % value. The OIC50 values were obtained 
from the fitted curved at the 50 % value. Flux time was 5 min. Number of individual 
determinations (n) for WT, TSC1-KO, and TSC2-KO cells were n = 6, 12 and 6, 
respectively. Values are means ± S.E. Details are discussed in the text. 
A summary of the ouabain effects on the Rb+ influx parameters described above is 
shown in Table 2 for WT, TSC1-KO and TSC2-KO MEF cells.  
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b) Summary of ouabain-dose-response of Rb+ Influx, OIC50 and OSmax in WT, 
TSC1-KO and TSC2-KO MEF cells.  
Half maximal ouabain inhibitory concentration (OIC50) and maximal ouabain-
sensitive Rb+ influx (OSmax), which are obtained for WT, TSC1-KO, and TSC2-KO cells, 
have been summarized in Table 2 to determine whether there is a difference in these 
parameters between the three cell types, in addition to other statistical variables. The table 
also lists the standard error (SE), range (minimum and maximum values) standard deviation 
(SD), number of individual determinations (n) and independent experiments (N) performed 
for WT, TSC1-KO, and TSC2-KO cells.  
Cells  WT  TSC1-KO  TSC2-KO  
OIC50  0.515  0.637  0.624  
SE  0.17  0.14  0.42  
RANGE  0.34 to 0.69  0.29 to 0.99  0.199 to 1.05  
SD  0.24  0.29  0.6  
OSmax  121.53  58.54 ** 61.84 ** 
SE  12.99  4.71  12.34  
RANGE  108.54 to 134.53  48.36 to 66.83  49.5 to 74.18  
SD  18.37  9.42  17.45  
n  6  12  6  
N  2  4  2  
35 
 
Table 2: Maximal ouabain-sensitive (OSmax) Rb+ influx (nmol/mg protein x 5 min) 
and half maximal ouabain inhibitory concentration (OIC50, mM), statistical 
parameters and number of individual determinations (n) and independent 
experiments (N) performed for WT, TSC1-KO, and TSC2-KO cells. 
 The conclusion from these data is that the OSmax was decreased by 50 % in the 
mutants whereas the affinity for ouabain was not altered. The underlying factor/s leading 
to a decrease in the maximal inhibition by ouabain in the absence of the TSC1 and TSC2 
genes could be explained by deregulation of the mTOR pathway, as it will be explained in 
the Discussion. 
4.3.  Studies on NKCC activity and the effect of ouabain in WT, TSC1-KO and 
TSC2-KO in MEF cells 
After studying  NKP activity in WT, TSC1-KO, and TSC2-KO MEFs and 
determining the optimal ouabain concentration for Rb+ influx and Ki content, which was 
found to be 2 mM, the next step was to assess the impact of absence of the TSC1 and TSC2 
genes and deregulation of the mTOR pathway could have on NKCC activity in these cells. 
The approach followed was similar to the studies with ouabain and consisted of determining 
the same parameters for bumetanide, i.e. BSmax and BIC50 for Rb+ influx and Ki content at 
different ouabain concentrations, 0, 0.1 and 2 mM, to learn whether there were also 
abnormalities for bumetanide inhibition in the mutant cells as those found for ouabain.  
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Figure 11 shows the bumetanide dose-response of Rb+ influx as a function of 
bumetanide (0-50 µM) at different ouabain concentrations (0, 0.1, 2 mM) in WT MEFs.  
Rb+ influx followed a hyperbolic function with no statistically different values for the three 
ouabain concentrations tested in the absence of bumetanide whereas at increasing 
concentrations of the inhibitor a trend for lower Rb+ influx values can be observed when 
ouabain increases from 0-2 mM. In spite of the differences between the bumetanide-dose 
response curves, saturation occurs at 20 µM bumetanide for the three cell types. Further 
analysis of the data, represented as the averages of Rb+ influx for each of the curves, is 
shown in Figure 12. Results show a tendency for the averages to decrease with increasing 
ouabain concentrations although not statistically significant due to the large dispersion of 
the data. 
The effect of ouabain on the dose-response of Ki content to increasing doses of 
bumetanide (0-50) and on their averages are shown in Figures 13 and 14, respectively. 
Neither the Ki content nor its averages were affected by bumetanide and ouabain in WT 
cells suggesting that outward K+ movements occur through neither NKP nor NKCC under 
the experimental conditions tested. 
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a) Determination of the optimal bumetanide concentration for Rb+ influx and 
Ki content in WT cells. 
 
 
Figure 11 – Bumetanide dose-response (BDR) of Rb+ influx in WT MEF cells and 
the effect of ouabain. Rb+ influx was determined as described in Materials and Methods 
as a function of bumetanide (0-50 μM), and at three different ouabain concentrations (0, 
0.1 and 2 mM). Flux time, 5 min. Number of individual determinations for WT MEF cells 




Figure 12 – Rb+ influx averages from bumetanide dose-response of Rb+ influx in WT 
MEF cells and the effect of ouabain. Rb+ influx was determined as described in 
Materials and Methods. The Rb+ influx averages were calculated from BDR curves in 
Figure 11 for each ouabain concentration and plotted as shown. Flux time, 5 min. Number 
of individual determinations for WT MEF cells was n = 4. Values are means ± S.E. 




Figure 13 - Bumetanide dose-response of Ki content in WT MEF cells and the effect 
of ouabain. Ki content was determined after 5 min of incubation in the corresponding 
flux media, as described in Materials and Methods, as a function of bumetanide (0-50 
μM), and at three different ouabain concentrations (0, 0.1 and 2 mM). Number of 
individual determinations for WT MEF cells was n = 4. Values are means ± S.E. Details 




Figure 14 – Ki content averages from bumetanide dose-response of Ki content in WT 
MEF cells and the effect of ouabain. Ki content was determined as described in 
Materials and Methods. Ki content averages at 5 min were calculated from BDR curves in 
Figure 13 for each ouabain concentration and plotted as shown. Number of individual 
determinations for WT MEF cells was n = 4. Values are means ± S.E. Details are 
discussed in the text. 
Like for ouabain, the maximal bumetanide inhibitory concentration (BSmax) was 
determined from the bumetanide-sensitive Rb+ influx (NKCC activity) as a function of 
bumetanide in WT cells at 0, 0.1, and 2 mM ouabain (Figure 15). As it should be expected, 
NKCC activity was not affected by different ouabain concentrations, and likewise the half 
41 
 
maximal bumetanide inhibitory concentration (BIC50) was not affected as shown in Figure 
16. 
 
Figure 15 - Determination of the maximal bumetanide inhibitory concentration 
(BSmax) in WT MEF cells and the effect of ouabain. Rb+ influx was determined as 
described in Materials and Methods and the bumetanide-sensitive (BS) fluxes were 
calculated from BDR curves (see Figure 11) for each bumetanide concentration. The 
BSmax was determined as the bumetanide dose at which saturation was reached. Flux time, 
5 min. Number of individual determinations for WT MEF cells was n = 4. Values are 




Figure 16 - Determination of the half maximal bumetanide inhibitory concentration 
(BIC50) in WT MEF cells and the effect of ouabain. Rb+ influx was determined as 
described in Materials and Methods and the bumetanide-sensitive (BS) fluxes were 
calculated from BDR curves (see Figure 11) for each bumetanide concentration. The 
bumetanide-sensitive Rb+ influxes were calculated as percent of BSmax, which was 
assigned arbitrarily a 100 % value for all curves. The BIC50 values were obtained from 
the fitted curve at the 50 % value. Flux time was 5 min. Number of individual 
determinations (n) for WT MEF cells was n = 4. Values are means ± S.E. Details are 




Figure 17 - Comparison of BSmax for WT, TSC1-KO, and TSC2-KO at zero ouabain. 
Rb+ influx was determined as described in Materials and Methods for each cell type in the 
absence of ouabain and the bumetanide-sensitive (BS) fluxes were calculated from BDR 
curves (see Figure 11) for each bumetanide concentration. The BSmax was determined as 
the bumetanide dose at which saturation was reached. Flux time was 5 min. Number of 
individual determinations for WT, TSC1-KO and TSC2-KO MEF cells were n = 4, 6 and 
10, respectively. Values are means ± S.E. Details are discussed in the text.  
The same approach followed for WT cells was applied to TSC1-KO and TSC2-KO 
MEF cells to determine BSmax and BIC50 at each ouabain concentration to assess whether 
there was any interaction between bumetanide and ouabain while inhibiting NKCC. Figures 
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17 and 18 show the bumetanide-sensitive Rb+ influx (NKCC) as a function of bumetanide 
for each of the three cell types, either at 0 or 2 mM ouabain, respectively, where the BSmax 
can be appreciated. Unexpectedly and in contrast to what was found for WT cells, BSmax 
values for the mutants were significantly lower at both 0 and 2 mM ouabain. The sequence 
found was WT > TSC1-KO > TSC2-KO, where the decrease for TSC1-KO and TSC2-KO 
was about 30 % and 50 %, and 50 % and 75 % at 0 and 2 mM ouabain, respectively, 






Figure 18 - Comparison of BSmax for WT, TSC1-KO, and TSC2-KO at 2 mM 
ouabain. Rb+ influx was determined as described in Materials and Methods for each cell 
type at 2 mM ouabain and the bumetanide-sensitive (BS) fluxes were calculated from 
BDR curves (see Figure 11) for each bumetanide concentration. The BSmax was 
determined as the bumetanide dose at which saturation was reached. Flux time was 5 min. 
Number of individual determinations (n) for WT, TSC1-KO and TSC2-KO MEF cells 
were n = 4, 6 and 10, respectively. Values are means ± S.E. Details are discussed in the 
text.  
Thus TSC2-KO cells showed larger changes than those of TSC1-KO for all the 
parameters determined, and especially, for the activity of bumetanide=sensitive Rb+ influx 
(NKCC) which was significantly reduced when compared not only to WT but also to TSC1-
KO cells (Figures 17 and 18).  
A summary of bumetanide effects on Rb+ influx in WT, TSC1-KO and TSC2-KO 
MEF cells and the effect of ouabain is shown in Table 3. 
b) Summary of bumetanide-dose-response of Rb+ Influx, IC50 and BSmax in 
WT, TSC1-KO and TSC2-KO MEF cells and the effect of ouabain. 
Half maximal bumetanide inhibitory concentration (BIC50) and maximal 
bumetanide-sensitive Rb+ influx (BSmax) at 0, 0.1, and 2 mM ouabain for WT, TSC1-KO, 
and TSC2-KO cells are summarized in Table 3 in order to see if there is a difference in 
46 
 
these parameters between the three cell types. BIC50 is is expressed in µM and BSmax in 
nmol/mg protein. 
Cells WT TSC1-KO TSC2-KO 
Ouab.  0 0.1 2 0 0.1 2 0 0.1 2 
BIC50  2.8 2.8 2.8 2.9 2.9 5.7 2.1 4.3 2.8 
SE - - - 0.6 0.85 2.2 0.4 2.6 1.2 
SD - - - 0.8 1.2 3.1 0.6 3.7 1.6 
BSmax 151 159 157 112 103 87* 71 37* 34** 
SE - - - 15.4 34.6 1.2 2.9 14 6.8 
SD - - - 21.8 49 1.7 4.1 120 9.7 
n 4 4 4 6 6 6 10 10 10 
N 1 1 1 2 2 2 4 4 4 
Table 3 - Maximal bumetanide-sensitive (BSmax) Rb+ influx and half maximal 
bumetanide inhibitory concentration (BIC50), statistical parameters and number of 
individual determinations (n) and independent experiments (N) performed for WT, 
TSC1-KO, and TSC2-KO cells at different ouabain concentrations (0, 0.1 and 2 
mM). 
Table 3 shows the BIC50 and BSmax for WT, TSC1-KO, and TSC2-KO MEF cells 
at 0, 0.1, and 2 mM ouabain. The BIC50 for the three cell types was not statistically different 
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with increasing ouabain between 0 to 2 mM, whereas the BSmax did show statistically 
significant differences for the effect of ouabain in a given cell type or between cell types at 
a given ouabain concentration. Thus, in WT, ouabain had no effect on BSmax, in contrast to 
the mutants where increasing ouabain was associated with decreasing BSmax. Larger 
changes were observed for TSC2-KO compared to TSC1-KO cells. In addition, the 
magnitude of the BSmax values followed the sequence WT > TSC1-KO > TSC2-KO, which 
resembles the trend observed for most of the variables determined in this study and where 
absence of the TSC2 gene appears to cause a more abnormal deregulation of the mTOR 
pathway than the absence of TSC1 [3, 53, 55, 56].  
One of the aims of this study was to assess the relative activities of the main 
pathways for K+ transport that are known to be involved in cell volume regulation, 
migration and proliferation. These are NKP, NKCC and KCC.  Another purpose was oto 
assess whether murine embryonic fibroblasts behave as adult cells in terms of their ion 
transport properties and to understand which of the two genes, TSC1 or TSC2, have a major 
impact if any on K+ homeostasis as determined by Rb+ influx and Ki content. The studies 
described above were designed to provide the optimal ouabain and bumetanide 
concentrations for the three cell types, WT, TSC1-KO and TSC2-KO MEF cells to 
accomplish this goal. The conclusion from such studies is that 2 mM ouabain and 20 μM 
bumetanide were the optimal concentrations to further assess the activity of the 
aforementioned pathways under more physiological conditions. 
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Figure 19 shows the Rb+ influx pathways measured at optimal ouabain (2 mM) and 
bumetanide concentrations (20 μM) for WT, TSC1-KO and TSC2-KO MEF cells. Rb+ 
influx was determined as described in Materials and Methods in the presence and absence 
of Cl-, ouabain and bumetanide to determine the activities of NKP, NKCC and KCC. In the 
upper panel, the Rb+ influx was measured in chloride (Cl), chloride + 2 mM ouabain (ClO), 
chloride + 2 mM ouabain + 20 µM bumetanide (ClOB) and sulfamate + 2 mM ouabain + 
20 µM bumetanide (SOB). In the lower panel, the calculated NKP, NKCC and KCC 
activities are represented for each cell type. It is clear from the figure that the major 
difference for all the variables studied appears in TSC2-KO cells where Rb+ influx in all 
the media, ± Cl- and ± inhibitors, and through the three transporters in question is 
significantly diminished when compared to both WT and TSC1-KO. For the latter, the only 
difference observed was a decrease in ClOB and consequently, a decrease in KCC. 
However, the NKCC activity, although elevated was not statistically different from that in 
WT cells. In these cells, NKP and NKCC contributed to 92 % of the total Rb+ influx 
whereas only 8 % of the influx occurred through KCC. The major contributor for Rb+ influx 
in WT cells was NKCC (68 %) followed by NKP (24 %) and KCC (8%).  
According to the hypothesis tested in this study, TSC1-KO and TSC2-KO MEF 
cells should have increased mTORC1 activity [44]. Increased mTORC1 activity affects the 
activity of NKCC as shown in mammalian skeletal muscle cells [41, 42, 44] and the 
expression of KCC as shown in human cells [43, 44]. In fact, the baseline NKCC activity 
in TSC1-KO cells was 90 % of the total Rb+ influx followed by NKP (5 %) and KCC (5 
%), in contrast to the values observed in WT cells. However, the total Rb+ influx through 
49 
 
NKP, NKCC, and KCC in WT and TSC1-KO cells was the same, whereas that of TSC2-
KO was less than 40 % when compared to WT and TSC1-KO and shown in [Fig.19].  
In conclusion, these findings are in agreement with studies on the effect of 
deregulation of the mTOR pathway on NKCC activity and KCC expression [41, 42, 43], 
and will be further analyzed in the Discussion. 
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Figure 19 – Rb+ influx pathways at optimal ouabain and bumetanide concentrations 
for WT, TSC1-KO and TSC2-KO MEF cells. Rb+ influx was determined as described 
in Materials and Methods in the presence and absence of Cl-, ouabain and bumetanide to 
determine the activities of NKP, NKCC and KCC at optimal inhibitor concentrations, 2 
mM ouabain and 20 uM bumetanide. Upper panel: Cl, ClO, ClOB and SOB. Lower 
panel: NKP, NKCC and KCC for each cell type. Flux time was 5 min and Rb+ influx 
components and transporters were calculated as described in Materials and Methods. 
Number of individual determinations (n) for WT, TSC1-KO and TSC2-KO MEF cells 





Figure 20: Ki content at optimal ouabain and bumetanide concentrations for WT, 
TSC1-KO and TSC2-KO MEF cells. Ki content was determined as described in 
Materials and Methods in the presence and absence of Cl-, ouabain and bumetanide at 
optimal inhibitor concentrations, 2 mM ouabain and 20 μM bumetanide in the 
corresponding media: Cl, ClO, ClOB and SOB for each cell type. Flux time was 5 min. 
Number of individual determinations for WT, TSC1-KO and TSC2-KO MEF cells were n 
= 12, 6 and 12, respectively. Values are means ± S.E. Details are discussed in the text.  
Figure 20 shows Ki content in WT, TSC1-KO and TSC2-KO MEF cells under the 
same conditions as described in Figure 19. In the mutant cells, Ki content was surprisingly 
low (~40 % in TSC1-KO and ~60 % in TSC2-KO lower compared to WT cells). The loss 
of K+ occurs through none of the transporters studied, as shown in the figure, and may be 
lost perhaps through an unidentified K+ channel that requires further exploration. 
4.5. Proposed model of the factors affecting Ki homeostasis in TSC1-KO and TSC2-
KO MEFs. 
 According to our hypothesis, when the TSC1 gene in MEF cells is mutated or 
knocked out, the mTORC1 activity increases [3-6] and consequently affects NKCC activity 
and KCC expression [3 - 6, 41 - 43]. As a result, highly active mTORC1 causes activation 
of NKCC and inhibition of KCC [4 - 6].  
This model explains the effect of the TSC1 and TSC2 genes on K+ homeostasis 
through the mTOR pathway in MEF cells. In the upper panel, the mutated TSC1 gene 
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increases mTORC1 activity and it may decrease NKP activity (Table 2 and Figs. 9 and 19). 
A decrease in NKP activity may be explained by consumption of ATP by mTORC1. ATP 
is needed in the NKP cycle to transport Na+ and K+, [44 - 47]. NKCC and KCC activities 
were statistically significantly increased and decreased, respectively, in TSC1-KO cells due 
to the effect of a highly active mTORC1 (Figs. 19 and 20). Lastly, the total magnitude of 
Rb+ (K+) influx through the three pathways was similar to that found in WT cells (Fig. 19) 
see the upper panel of (Fig. 21). 
On the other hand, as shown in the lower panel of this model, a mutated TSC2 gene 
increases the mTORC1 activity, as it occurs in TSC1-KO cells, and it may decrease the 
NKP activity (Table 2 and Figs. 9 and 19), as seen in TSC1-KO cells (Figs. 19 and 20). 
However, the striking difference between the two mutants is the low magnitude of Rb+ (K+) 
influx and Ki content in TSC2-KO cells (Figs. 4 – 9, Table 2 and 3)  compared to WT and 




Figure 21. Hypothetical model of the factors affecting Ki homeostasis in TSC1-KO 
and TSC2-KO MEFs. 1 = activation of mTORC1 as a result of mutation in the TSC1 
or TSC2 genes. Higher activity of mTORC1 causes 2 = less NKP activity, 3 = 
activation of NKCC, and 4 = less expression of KCC. Big K+ means higher 
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intracellular potassium in TSC1-KO cells (upper panel). Small K+ means lower 
intracellular potassium in TSC2-KO cells (lower panel). 
 5.  Discussion  
  The TSC1-TSC2 complex plays a crucial role in the inhibition of mTORC1 and 
activation of mTORC2, and ultimately in the regulation of NKCC activity and KCC 
expression  through a negative feedback process involving S6K1, Akt, IGF-1, and several 
other proteins [4, 5, 6, 41, 42, 43] because mTORC1 phosphorylates S6K1, while 
(mTORC2) phosphorylates Akt [3, 5]. Highly active S6K1 causes feedback inhibition of 
IRS-1 leads to inability of insulin or IGF1 to activate PI3K and subsequently Akt [3, 4, 5, 
25].  
The present study investigated the role of the TSC1 and TSC2 genes, and indirectly, 
of the mTOR pathway on cellular K+ homeostasis in WT, TSC1-KO, and TSC2-KO MEF 
cells. The approach was to measure Rb+ influx and Ki content to assess the impact of these 
genes on the K+ transporters, NKP, NKCC and KCC, known to be involved in K+ 
homeostasis, cell volume regulation, proliferation, migration and in other cellular metabolic 
processes [1, 32, 43, 51, 58]. Our main findings show that in MEF cells overall, the 
activities of the transporters studied followed the sequence NKCC > NKP > KCC, which 
resemble findings in adult murine cells. However, there were differences in their relative 
magnitudes within and across cell types. For instance, in the mutants, the activities of NKP 
and KCC were statistically lower than in WT cells whereas NKCC was 25 % greater in 
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TSC1-KO than in WT, and in TSC2-KO cells, where it was about 70 % lower than for both 
WT and TSC1-KO cells (Fig.19). 
The decreased NKP activity in knockout cells, about 50% less than in WT cells 
(Table 2 and Figs. 9 and 19), may be explained by extensive consumption of ATP, which 
is needed in the NKP cycle to transport Na+ and K+, by mTORC1. As a matter of fact, 
TSC1-KO and TSC2-KO cells are considered models of increased mTORC1 activity [44, 
45, 46, 47]. However, the averages of Rb+ influx and Ki content in TSC2-KO cells are 
considerably less than in TSC1-KO and WT cells. A plausible explanation may lie on the 
magnitude of NKCC activity in TSC1-KO compared to TSC2-KO which can transport Rb+ 
(K+) inward or outward depending on the gradient. Further studies on NKCC and KCC are 
needed to address this particular point. 
The mTORC1 activity is increased in cells lacking either the TSC1 (hamartin) 
and/or TSC2 (tuberin) genes, which in turn affect the activity of NKCC and the expression 
of KCC [41, 43, 44], through a negative feedback inhibition of insulin receptor substrate 1 
(IRS-1), as shown in mammalian skeletal muscle and human cells. Therefore, the 
mTORC1-driven feedback inhibition of IRS-1 prevents insulin or IGF1 to activate PI3K 
and subsequently Akt [41 - 43, 45]. Thus, defects in the TSC1-TSC2 complex activate 
mTORC1 and S6K1 constitutively. This activation of S6K1 hyper phosphorylates and 
degrades IRS-1. As a result of the IRS-1 degradation, the PI3K signaling will be attenuated. 
PI3K affects the phosphorylation of Akt, so expression of KCC will be decreased and 
activity of NKCC will be increased [41 - 43, 45] because KCC expression and NKCC 
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activity are dependent on Akt in opposite ways which means when Akt is attenuated, KCC 
expression decreases and NKCC activity increases.  
In our results the baseline NKCC activity was 90 % of the total Rb+ influx, followed 
by NKP (5 %) and KCC (5 %) in TSC1-KO cells as shown in (fig. 19), in contrast to the 
values observed in WT cells These findings are in agreement with reports in mammalian 
skeletal muscle and human cells where the activities of NKCC and KCC were increased 
and decreased, respectively, in cells lacking the TSC1 and TSC2 genes. Likewise, in TSC2-
KO cells, albeit possessing lower NKCC and KCC activities than in TSC1-KO cells, NKCC 
was the predominant pathway, whereas KCC was the minor route for K+ movements (Fig. 
19), fulfilling the predictions of our hypothesis.  
According to various studies on the affinity of ouabain for NKP in human cells 
(HEK293), the concentrations of ouabain to inhibit NKP are in the µM range (~ 0.1 mM) 
[57, 58]. However, in mouse cells, the concentrations are in the mM range (~ 1 mM) [59]. 
In our studies, in order to determine the optimal ouabain concentration to inhibit NKP in 
MEF cells, we have done ouabain dose-response (ODR) curves for Rb+ influx [Figures 5 
and 6] and Ki content [Figures 7 and 8] and we found that the OIC50 was ~ 0.5 mM for both 
WT and mutant cells and OSmax was around 121 nmoles/mg protein for WT cells, but for 
the mutants cells the OSmax was ~ 60 nmoles/mg protein (Table 2). Thus, the optimal 
ouabain concentration in these cells was 2 mM [Figures 5 and 9].  
Therefore, the relative values of Rb+ influx followed the sequence WT > TSC1-KO 
> TSC2-KO at 0 mM ouabain, whereas that of the mean values obtained by averaging the 
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Rb+ influx from the ODR curves for each cell type was WT ~ TSC1-KO > TSC2-KO 
[Figures 6 and 8]. In addition, there was no difference in the OIC50s (~ 0.5 mM) (Table 2) 
and for the OSmax the sequence was WT > TSC1-KO ~ TSC2-KO (Table 2). As a 
conclusion, ouabain binds with low affinity to NKP in MEF cells compared to human 
erythrocytes (IC50 ~ 4 x 10-8 M) [66]. Our results are also in agreement with findings in 
adult murine cells. 
On the other hand, the bumetanide concentrations to block NKCC in primary rat 
neurons cells are in the µM range. For instance, at ~ 10 µM there is strong inhibition of 
NKCC [60]. However, in our studies with MEF cells, the actual values were not known. 
Thus, to  determine the optimal bumetanide concentration, we have done bumetanide dose-
response (BDR) curves for Rb+ influx [Figures 11 and 12] and Ki content [Figures 13 and 
14] and found that 20 µM bumetanide was the optimal concentration to  maximally inhibit 
NKCC at 0, 0.1, and 2 mM ouabain in the three cell types [Figs. 11, 15, 17, and 18]. In 
addition, we determined the maximal bumetanide-sensitive Rb+ influx (BSmax) and the half 
maximal bumetanide inhibitory concentration (BIC50) at different ouabain concentrations 
[Figs. 15 - 18]. The relative values of Rb+ influx followed the sequence WT > TSC1-KO > 
TSC2-KO at 0, 0.1, and 2 mM ouabain whereas that of the mean values obtained by 
averaging the Rb+ influx from the ODR curves for each cell type was WT > TSC1-KO > 
TSC2-KO at 0, 0.1, and 2 mM ouabain. In conclusion, while ouabain did not affect the 
BIC50 as a function of its concentration for the three cell types (~ 3 µM), it did affect the 
maximal activity of NKCC both as a function of ouabain concentration in the mutants and 
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in TSC2-KO more than in TSC1-KO, but  not in WT cells (figures 17 and 18 and Table 3). 
Also, mouse cells needs slightly more bumetanide concentration (20 µM) to inhibit NKCC 
comparing to rat neuron cells (10 µM) which means that MEF cells have merely less affinity 
for bumetanide compared to rat cells [60]. 
In conclusion, the major findings in this study support the hypothesis proposing that 
the TSC1 and TSC2 genes, which control cell processes through the mTOR pathway, are 
important for K+ homeostasis where the activities of NKP were reduced, NKCC increased 
and KCC decreased, according to expectations and the proposed model (figures 21). 
Furthermore, cells lacking the TSC2 gene showed more striking changes concerning K+ 
homeostasis than those seen in cells lacking the TSC1 gene (Figures; 4, 6, 8, 17, 18, 19, 20, 
and Tables 2 and 3). Furthermore, the distinct abnormalities in ion transport of TSC2-KO 
compared to TSC1-KO and WT cells parallels the pathological manifestation and incidence 
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     AMPK, AMP-activated kinase which is an enzyme that plays a role in cellular 
energy homeostasis; 4E-BP, eIF4E binding protein is a protein that play an important 
role in the control of protein synthesis, survival, and cell growth, eIF4E, eukaryotic 
initiation factor 4E is a cap-binding protein that participates in recruitment of mRNA 
to the ribosome; Mnk1, mitogen-activated protein kinase-interacting kinase 1; 
mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of 
rapamycin complex 2; PDK1, phosphoinositide-dependent protein kinase 1; 
PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-triphosphate; PtdIns(4,5)P2, 
phosphatidylinositol-4,5-bisphosphate; raptor, regulatory associated protein of tor; 
rictor, rapamycin-insensitive companion of mtor; S6, ribosomal protein S6; S6K, 
p70S6 kinase; S473, serine 473; T308, threonine 308; TSC, tuberous sclerosis complex; 
RVD, regulatory volume decrease; RVI, regulatory volume increase; NKP, Na+/K+ 
pump; NKCC, Na+-K+-2Cl- co-transporter; KCC, K-Cl cotransport; mTOR, 
mammalian target of rapamycin; TSC1, tuberous sclerosis complex 1; TSC2, tuberous 
sclerosis complex 2; MEFs, mouse embryonic fibroblasts; MEFs WT, mouse 
embryonic fibroblasts wild type; MEFs TSC1-KO, mouse embryonic fibroblasts-
tuberous sclerosis complex 1 knockout; MEFs TSC2-KO, mouse embryonic 
fibroblasts-tuberous sclerosis complex 2 knockout; CDK1, cyclin-dependent kinase 1; 
GSK3β, glycogen synthase 3β; ERK2, extra cellular related kinase 2; MK2, mitogen-
activated protein kinase–activated protein kinase 2; AKT/PKB, protein kinase b; RSK1, 
p90 ribosomal s6 kinase 1; GAP, GTP-ase activating protein; PI3K, 
phosphatidylinositol-4,5-bisphosphate 3-kinase; AICAR, 5-amino-4-
imidazolecarboxamide ribose; Rheb, RAS homolog enriched in brain; FRAP1, fk506-
binding protein 12-rapamycin-associated protein 1; mLST8, mammalian lethal with 
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sec13 protein 8; mSIN1, mammalian stress-activated protein kinase (sapk)-interacting 
protein 1; FKBP12, FK506 binding protein; FRB, FKBP12-rapamycin binding; IGF-1, 
insulin-like growth factor 1; IGF-2, insulin-like growth factor 2; S6K1, ribosomal 
protein s6 kinase beta-1; ROS, reactive oxygen species; ATP, adenosine triphosphate; 
slc12a2, solute carrier family 12 (sodium/potassium/chloride transporter), member 2; 
slc12a1, solute carrier family 12 (sodium/potassium/chloride transporter), member 1; 
PKC, protein kinase c; PKA, protein kinase a; CNS, central nervous system. 
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